{"contentid": 488529, "importid": NaN, "name": "EC approval for Advicenne\u00e2\u0080\u0099s ADV7103/Sibnayal", "introduction": "The European Commission (EC) has granted marketing authorization to ADV7103 (potassium citrate/potassium hydrogen carbonate), proposed trade name Sibnayal, for the treatment of distal renal tubular acidosis (dRTA), says French biotech Advicenne.", "content": "<p>The European Commission (EC) has granted marketing authorization to ADV7103 (potassium citrate/potassium hydrogen carbonate), proposed trade name Sibnayal, for the treatment of distal renal tubular acidosis (dRTA), says French biotech Advicenne (Euronext: ADVIC).<br /> <br /> This approval makes ADV7103 the first and only label-approved drug for the treatment of dRTA in adults, adolescents and children aged one year and older. With the approval, Advicenne has the opportunity to make a significant difference to patients suffering from dRTA, classified as an orphan condition affecting no more than 1 to 2 individuals per 10,000 people in Europe.<br /> <br /> The EC marketing authorization will be valid in all European Union member states, as well as in the European Economic Area (EEA) countries (Iceland, Liechtenstein and Norway).</p>\n<h2><strong>Management changes as recently-appointed CEO quits</strong></h2>\n<p>Advicenne also yesterday announced several changes in governance and in its senior leadership team.</p>\n<p>Peter Meeus is leaving his position as chief executive for personal reasons with immediate effect. Mr Meeus only <a href=\"https://www.thepharmaletter.com/article/peter-meeus-to-move-from-biocon-to-become-advicenne-ceo\">joined the French company in February</a> this year, moving from Biocon Biologics (NSE: BIOCON), and news of his departure saw Advicenne&rsquo;s shares plunge 13.5% to 11.66 euros by late morning, despite the positive development on ADV103.</p>\n<p>In his place, the board has appointed Didier Laurens. Mr Laurens is a highly experienced executive who is currently serving as chief financial officer of surgical robotics company eCential Robotics. Prior to this, he served as CFO for Pixium Vision and as investor relations, treasury and financing director for Korian, a company specialized in care for the elderly. Advicenne&rsquo;s chairman David Solomon will also assume an expanded role including new responsibilities to ensure a smooth transition of CEO duties to Mr Laurens.</p>\n<p>The company had requested that Euronext suspend the listing of its shares during the trading session of May 3.</p>", "date": "2021-05-04 11:44:00", "meta_title": "EC approval for Advicenne\u00e2\u0080\u0099s ADV7103/Sibnayal", "meta_keywords": "Advicenne, ADV7103, Sibnayal, Approval, European Commission, dRTA, Chief executive, CEO, Resignation, Appointment, Peter Meeus, Didier Laurens", "meta_description": "EC approval for Advicenne\u00e2\u0080\u0099s ADV7103/Sibnayal", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-04 11:43:44", "updated": "2021-05-04 11:53:24", "access": NaN, "url": "https://www.thepharmaletter.com/article/ec-approval-for-advicenne-s-adv7103-sibnayal", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "advicenne_large-1.jpg", "image2id": "advicenne_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Rare diseases", "topic_tag": "Boardroom, European Medicines Agency, Focus On, Management, One to Watch Companies, Regulation", "geography_tag": "Europe, France", "company_tag": "Advicenne", "drug_tag": "Sibnayal", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-04 11:44:00"}